ACON Biotech Co.

What ACON Biotech Co. does

ACON Biotech Co. (艾康生物技术（杭州）有限公司) is a privately held Chinese in vitro diagnostics (IVD) company founded in 1995 and headquartered in Hangzhou, Zhejiang. The company develops, manufactures, and distributes diagnostic reagents and instruments spanning five major categories: rapid testing, biochemical diagnostics, chronic disease management, immunodiagnostics, and molecular diagnostics. Its flagship Flowflex® brand encompasses more than 100 diagnostic products, including cardiac markers (cTnI, CK-MB, Myo, NT-proBNP, D-dimer), inflammation markers (CRP, SAA, PCT, IL-6), HbA1c for diabetes monitoring, specific IgE panels for allergy screening, H. pylori detection for gastric function, and infectious disease panels covering HIV, hepatitis, syphilis, and COVID-19. The company has earned three consecutive appearances on the Forbes China Potential 100 list.

The company's technology platform is built on four core methodologies: fluorescence immunochromatography with time-resolved measurement and built-in temperature compensation, colloidal gold immunochromatography, latex immunochromatography, and nucleic acid molecular hybridization. Hardware platforms include the Flowflex® iFIA-100 dry fluorescence immunoassay analyzer (a benchtop reader with QR-code-based calibration, 7-inch touchscreen, and 5,000-test database capacity) and the Promotor® NAH-960 Plus automated nucleic acid hybridization instrument. The company holds US FDA, European CE, and ISO 13485 certifications, along with multiple Chinese NMPA (国家械注准) product registrations, and claims 100+ patent applications.

ACON Biotech operates through direct enterprise sales to hospitals, clinical laboratories, and primary care institutions (基层医疗机构) in China, alongside channel partner and distributor arrangements via dedicated international websites (aconlabs.com for clinical products, acondiabetescare.com for diabetes care). Distribution covers 14 global regions including North America, Europe, Eastern Europe, the CIS, the Middle East, Africa, South Asia, Southeast Asia, Oceania, South America, and China. Revenue is generated through the sale of consumable reagent kits and capital diagnostic equipment, with no public pricing disclosed. Products feature room-temperature storage (2–30°C) and 12–24 month shelf life, supporting distribution economics across varied climates and channels.

Name

ACON Biotech Co.

Legal name

艾康生物技术（杭州）有限公司

Website

https://aconlabs.com.cn

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

ACON Biotech Co. is a Hangzhou-based privately held in vitro diagnostics company (founded 1995) developing 100+ diagnostic reagents and instruments under the Flowflex® brand for clinical laboratories, hospitals, and primary care institutions across 14 global regions.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Autoimmune & Allergy Diagnostics (HLAAALAK), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

Keywords

• In vitro diagnostics
• Rapid diagnostic tests
• Immunodiagnostic reagents
• Molecular diagnostics
• Chronic disease management

Headquarters

HQ city

Hangzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. In Vitro Diagnostic Reagents (Rapid Detection): ACON Biotech manufactures and sells rapid in vitro diagnostic reagents across multiple categories: inflammation, cardiac markers, diabetes, gastric function, allergy, gastrointestinal, infectious diseases, and COVID-19. These are one-time purchase consumable products sold to clinical laboratories, hospitals, and primary care institutions.
2. Diagnostic Instruments and Analyzers: Sale of diagnostic instruments including the Flowflex® iFIA-100 dry fluorescence immunoassay analyzer and Promotor® NAH-960 Plus automated nucleic acid molecular hybridization instrument. These are capital equipment purchases by laboratories and healthcare facilities.
3. Molecular Diagnostics Products: Molecular diagnostic reagents and instruments covering hepatitis, sexually transmitted diseases, tumors, respiratory infections, gastrointestinal infections, prenatal screening, and genetic disease testing.
4. Chronic Disease Management Products: Products for blood glucose monitoring, blood lipid testing, handheld urine testing, and HbA1c detection targeting diabetes and chronic disease management in primary care settings.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

ACON Biotech manufactures and sells in vitro diagnostic (IVD) reagents and instruments across five categories: rapid diagnostics, biochemical diagnostics, immunodiagnostics, molecular diagnostics, and chronic disease management. Its portfolio includes over 100 diagnostic products under the Flowflex® brand covering cardiac, inflammation, allergy, gastrointestinal, infectious disease, gastric function, and diabetes biomarkers, plus capital instruments such as the iFIA-100 dry fluorescence immunoassay analyzer, the Promotor® NAH-960 Plus automated nucleic acid molecular hybridization instrument, and the Hb Cuvette hemoglobin analysis system.

Product overview

ACON Biotech Co. (艾康生物技术（杭州）有限公司) is a diagnostic company founded in 1995 offering a comprehensive portfolio of over 100 diagnostic products across five major categories: Rapid Testing (快速诊断), Biochemical Diagnostics (生化诊断), Chronic Disease Management (慢病管理), Immunodiagnostics (免疫诊断), and Molecular Diagnostics (分子诊断). The core product brand is Flowflex®, which encompasses rapid test reagents including cardiac markers (cTnI, Myo, CK-MB, NT-proBNP, D-dimer), inflammation markers (CRP, SAA, PCT, IL-6), allergy tests (total IgE and specific allergen panels), gastrointestinal tests (H. pylori, fecal occult blood), infectious disease screening (HIV, hepatitis B/C, syphilis), and gastric function tests (pepsinogen, gastrin-17). The company also produces the iFIA-100 fluorescence immunoassay analyzer as supporting instrumentation and the Promotor® NAH-960 Plus for molecular diagnostics. Products use various methodologies including fluorescence immunochromatography, colloidal gold, latex agglutination, and molecular hybridization.

Differentiator

Problem solved

Functional benefit

Brands

• Flowflex: Brand for rapid diagnostic test reagents including cardiac markers, inflammation markers, infectious disease tests, allergy tests, and gastrointestinal tests
• Promotor
• Foresight

Products and services

• Flowflex® iFIA-100 Dry Fluorescence Immunoassay Analyzer A benchtop fluorescence immunoassay analyzer that reads and interprets test results from Flowflex fluorescence-labeled reagent cards for clinical laboratories and primary healthcare institutions. Uses time-resolved measurement technology with built-in temperature compensation for accuracy.
• Promotor® NAH-960 Plus Automated Nucleic Acid Molecular Hybridization Instrument A high-throughput automated nucleic acid molecular hybridization instrument used in clinical molecular diagnostics laboratories for hepatitis, sexually transmitted disease, tumor, respiratory infection, gastrointestinal infection, prenatal screening, and genetic disease testing.
• Hb Cuvette Hemoglobin Analysis System A hemoglobin analysis system using siphon micro-sampling with second-level precision, targeting diabetes monitoring in primary healthcare institutions and clinical laboratories.
• Flowflex® Inflammation Series Reagent Kits A product line of fluorescence immunochromatography reagent kits for quantitative detection of CRP, SAA, PCT, and IL-6 biomarkers used in clinical laboratories to differentiate bacterial from viral infections and to monitor inflammatory and sepsis conditions.
• Flowflex® Cardiac Markers Series Reagent Kits A product line of fluorescence immunochromatography reagent kits for quantitative detection of cardiac biomarkers including cTnI, CK-MB, Myo, NT-proBNP, and D-dimer used by clinical laboratories and emergency departments for acute myocardial infarction diagnosis and cardiac monitoring.
• Flowflex® Infectious Disease Series Reagent Kits A product line of colloidal gold and latex reagent kits for qualitative detection of HIV-1/2 antibodies, hepatitis B surface antigen and five-marker panel, hepatitis C antibodies, and syphilis antibodies, plus a four-infection combined panel for clinical and primary care screening.
• Flowflex® COVID-19 (2019-nCoV) Antigen Test Kit (Latex Method) A rapid latex immunochromatography test kit for qualitative detection of SARS-CoV-2 N antigen from nasal and pharyngeal swabs, providing 15-minute results for clinical, primary care, and point-of-care COVID-19 screening.
• Flowflex® Allergy-Specific IgE Antibody Test Panels A product line of fluorescence immunoassay reagents for quantitative total IgE and qualitative allergen-specific IgE antibody detection across animal proteins, foods (eggs, milk, nuts, fruits, seafood), pollens (trees, weeds, grasses), and indoor allergens, used in clinical allergy screening.
• Flowflex® Gastric Function Series Reagent Kits A product line of fluorescence immunoassay reagents for qualitative detection of H. pylori antibodies (including Urease, CagA, VacA) and quantitative detection of pepsinogen I/II and gastrin-17, used in clinical laboratories for gastric function and gastric cancer risk assessment.
• Flowflex® Gastrointestinal Series Reagent Kits A product line of colloidal gold and latex reagent kits for fecal occult blood detection and H. pylori IgG antibody detection for gastrointestinal bleeding and infection screening in clinical and primary care settings.
• Flowflex® Glycosylated Hemoglobin (HbA1c) Test Reagents Fluorescence immunochromatography reagents for quantitative detection of glycosylated hemoglobin (HbA1c) used for diabetes monitoring in primary healthcare institutions and clinical laboratories.
• ACON Biochemical Diagnostics Line Biochemical diagnostic products for routine blood examination, urine analysis, and primary healthcare testing, distributed through ACON's clinical laboratory solutions for hospitals and grassroots medical institutions.
• ACON Chronic Disease Management Products Products for chronic disease management including blood glucose meters, blood lipid testing, handheld urine testing, and HbA1c detection, marketed under the ACON Diabetes Care brand (acondiabetescare.com) for diabetes and chronic disease patients and primary care.

Quantifiable outcome

• 100+ diagnostic products across 5 major categories (rapid detection, biochemical diagnosis, chronic disease management, immunodiagnostics, molecular diagnostics)
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Snibe (Shenzhen New Industries Biomedical Engineering): Chinese IVD peer specializing in chemiluminescence immunoassay systems and reagent kits for hospital laboratories; comparable in product breadth (cardiac, inflammation, infectious disease, hormones) and target customer segments.
• Autobio Diagnostics: Chinese IVD company focused on chemiluminescence immunoassay, microbiology, and clinical chemistry analyzers with a broad reagent menu sold into hospital laboratories — directly comparable to ACON's immunodiagnostics and biochemistry offerings.
• Mindray: Shenzhen-headquartered Chinese IVD and medical-device major with overlapping reagent and analyzer portfolios (clinical chemistry, immunoassay, hematology, rapid diagnostics). Closest large-scale domestic comparable given shared customer base of hospitals and clinical labs across China and international markets.
• Hologic: US-based diagnostics and molecular testing company with strong molecular diagnostics instrumentation and assay menus; comparable to ACON's Promotor molecular hybridization platform and hospital-laboratory go-to-market model.
• Wantai Biological Pharmacy: Chinese diagnostics manufacturer with a strong focus on lateral-flow and rapid test reagents (HIV, hepatitis, infectious disease), directly competing with Flowflex colloidal-gold and latex product lines in both China and export markets.
• QuidelOrtho: US-headquartered rapid diagnostics specialist with strong lateral-flow and immunoassay product lines (cardiac, infectious disease, women's health); closest Western direct comparable given similar product format and methodology.

Broad incumbents

• Roche Diagnostics: Global IVD leader offering broad clinical chemistry, immunoassay, cardiac, infectious disease and molecular diagnostics menus — the dominant incumbent against whom ACON competes for tier-1 hospital accounts in China and international markets.
• Bio-Rad Laboratories: Global life-science tools and clinical diagnostics company spanning quality controls, immunoassays, and molecular diagnostics; comparable to ACON's broad multi-platform reagent portfolio and laboratory-customer focus.
• Abbott Diagnostics: Global diagnostics incumbent with rapid test, immunoassay, and point-of-care platforms; directly overlaps with ACON's rapid cardiac, infectious disease, and POCT franchises and competes aggressively for primary-care accounts.

Regional players

• Hangzhou Lifeng Bio-Technology (Livzon Diagnostics): Chinese diagnostics group with rapid test, ELISA, and chemiluminescence product lines competing in overlapping reagent categories (infectious disease, hepatitis, cardiac) within China's hospital and primary-care channels.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ACON Biotech Co.